{"id":759,"date":"2026-04-07T23:03:07","date_gmt":"2026-04-07T19:03:07","guid":{"rendered":"https:\/\/healthfinder.ae\/blog\/?p=759"},"modified":"2026-04-08T15:36:04","modified_gmt":"2026-04-08T11:36:04","slug":"uae-nafld-protocols-2025-sgpt-bmi-fibroscan-diet-plan","status":"publish","type":"post","link":"https:\/\/healthfinder.ae\/blog\/uae-nafld-protocols-2025-sgpt-bmi-fibroscan-diet-plan\/","title":{"rendered":"NAFLD Protocols UAE 2025: SGPT Trends, BMI Cutoffs, FibroScan Insights & Liver Diet Plan"},"content":{"rendered":"

In the UAE, non-alcoholic fatty liver disease (NAFLD) has become a silent epidemic\u2014impacting a growing number of both Emirati and expat populations. Driven by modern lifestyle factors like obesity, insulin resistance, and sedentary habits, NAFLD now ranks among the most common liver conditions nationwide. Unlike alcohol-related liver disease, NAFLD develops in those who drink little or no alcohol but still face the risk of serious liver damage\u2014from simple fat buildup (steatosis) to inflammation (NASH), fibrosis, and even cirrhosis.<\/span><\/p>\n

As of 2025, healthcare authorities in the UAE\u2014including DHA, SEHA, and private centers\u2014have adopted more advanced, UAE-specific protocols for early detection. These involve a combination of BMI tracking, SGPT\/ALT enzyme monitoring, glucose levels, and imaging techniques like FibroScan. Persistently high ALT levels\u2014especially above 45 U\/L in males or 34 U\/L in females\u2014are a critical red flag when paired with metabolic risk markers.<\/span><\/p>\n

Whether you\u2019re a concerned patient or a clinician shaping care pathways, this guide decodes the latest NAFLD strategies in the UAE. We\u2019ll explore diagnostic protocols, local lab thresholds, diet plans, and how early lifestyle changes can transform outcomes.<\/span><\/p>\n

Understanding NAFLD \u2013 Definition, Stages & UAE Relevance<\/strong><\/span><\/h3>\n

Non-alcoholic fatty liver disease (NAFLD) is a common liver condition where fat builds up in the liver cells of individuals who drink little to no alcohol. In the UAE, NAFLD has become increasingly prevalent due to high rates of obesity, type 2 diabetes, and inactive lifestyles\u2014affecting both Emiratis and expatriates.<\/span><\/p>\n

Understanding the stages of NAFLD is essential for early diagnosis and prevention, especially because most people experience no symptoms until the disease has advanced.<\/span><\/p>\n

\"NAFLD<\/p>\n

Stage 1: Simple Fatty Liver (Steatosis)<\/strong><\/span><\/h3>\n

At this early stage, fat is present in liver cells but there\u2019s no inflammation or damage. Most patients are unaware they have it, and it\u2019s usually detected during routine blood tests. In UAE clinics, elevated liver enzymes\u2014particularly SGPT (ALT)\u2014often raise the first red flag.<\/span><\/p>\n

Stage 2: Non-Alcoholic Steatohepatitis (NASH)<\/strong><\/span><\/h3>\n

This stage involves liver inflammation and damage. Blood tests typically reveal higher SGPT levels, especially in patients with additional metabolic risks like high blood sugar or cholesterol. In the UAE, early-stage NASH is being identified more frequently due to proactive screening in high-risk individuals.<\/span><\/p>\n

Stage 3: Fibrosis<\/strong><\/span><\/h3>\n

Fibrosis means the liver has begun forming scar tissue due to ongoing damage. Although SGPT levels might normalize, internal damage progresses silently. This makes imaging tools like FibroScan<\/strong>, now commonly available at Aster, NMC, and SEHA<\/strong> facilities, crucial for accurate diagnosis.<\/span><\/p>\n

Stage 4: Cirrhosis<\/strong><\/span><\/h3>\n

At this advanced stage, the liver is severely scarred and its ability to function declines. Without proper treatment, patients face risks of liver failure or even liver cancer. Some cases may require a liver transplant<\/strong>, highlighting the importance of early intervention.<\/span><\/p>\n

Early detection of NAFLD\u2014especially using UAE-specific protocols like SGPT monitoring and FibroScan imaging\u2014can prevent disease progression and avoid serious complications.<\/span><\/p>\n

BMI & Waist Circumference: Key NAFLD Risk Factors in the UAE (2025)<\/strong><\/span><\/h2>\n

When it comes to liver health in the UAE, stepping on the scale isn\u2019t enough. Doctors now rely on two key metrics to detect non-alcoholic fatty liver disease (NAFLD) early: Body Mass Index (BMI) and waist circumference. These simple measurements can reveal hidden liver fat\u2014even in people who feel healthy and have no symptoms.<\/span><\/p>\n

BMI Cutoffs for NAFLD Screening in UAE Clinics<\/strong><\/span><\/h3>\n

BMI is calculated using your height and weight, and helps estimate your body fat. In 2025, most UAE healthcare centers\u2014including DHA and SEHA\u2014use the following BMI scale for NAFLD risk:<\/span><\/p>\n\n\n\n\n\n\n\n
BMI (kg\/m\u00b2)<\/strong><\/span><\/th>\nWeight Category<\/strong><\/span><\/th>\nNAFLD Risk Level<\/strong><\/span><\/th>\n<\/tr>\n<\/thead>\n
Under 23<\/span><\/td>\nHealthy<\/span><\/td>\nLow risk<\/span><\/td>\n<\/tr>\n
23\u201324.9<\/span><\/td>\nOverweight<\/span><\/td>\nModerate risk<\/span><\/td>\n<\/tr>\n
25 or above<\/span><\/td>\nObese<\/span><\/td>\nHigh risk<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

For Arab and Asian populations, NAFLD can occur even at lower BMIs. That\u2019s why UAE clinics start screening at 23, unlike the Western cutoff of 25.<\/span><\/p>\n

Waist Circumference: A More Accurate Predictor of Liver Fat<\/strong><\/span><\/h3>\n

Visceral fat (fat around your waist) is one of the strongest indicators of liver fat buildup. Even people with a normal BMI may have high liver fat if their waist size is above these thresholds:<\/span><\/p>\n\n\n\n\n\n\n
Waist Size<\/strong><\/span><\/th>\nGender<\/strong><\/span><\/th>\nNAFLD Risk<\/strong><\/span><\/th>\n<\/tr>\n<\/thead>\n
\u2265 90 cm (35.4 in)<\/span><\/td>\nMen<\/span><\/td>\nElevated<\/span><\/td>\n<\/tr>\n
\u2265 80 cm (31.5 in)<\/span><\/td>\nWomen<\/span><\/td>\nElevated<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

In the UAE, nutritionists, endocrinologists, and family doctors now measure waist circumference as part of annual checkups\u2014especially for people with diabetes, PCOS, or sedentary office jobs.<\/span><\/p>\n

NAFLD Can Happen Even If You\u2019re Not Overweight?<\/strong><\/span><\/h3>\n

This condition, called \u201clean NAFLD,\u201d is becoming more common in the Gulf. That\u2019s why doctors look at waist size + liver enzyme levels (like SGPT\/ALT) to decide if liver imaging or a referral to a hepatologist is needed.<\/span><\/p>\n

UAE clinics like Aster and LLH often combine:<\/span><\/p>\n